Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2008
06/19/2008US20080145365 Human and mammalian stem cell-derived neuron survival factors
06/19/2008US20080145363 Using vascular endothelial growth factor specific immunoglobulin as tool in diagnosis, prevention and treatment of cell proliferative, respiratory, vision and inflammatory disorders
06/19/2008US20080145362 Antibody combination useful for tumor therapy
06/19/2008US20080145359 Imaging, diagnosis and treatment of disease
06/19/2008US20080145358 Method for Determining Responsiveness to Chk1 Inhibitors
06/19/2008US20080145354 Polyoxyethylene glycol; biocompatability; bioavailability
06/19/2008US20080145347 p-Hyde sequences in the Rat
06/19/2008US20080145336 Use of isoindol-1-one or 1,3-dione compounds for treating cancer, angiogenesis inhibition or phosphodiesterase-4 inhibition; use with various other biodrugs and drugs
06/19/2008US20080145313 Treatment of cancer by means of RNA interference; compositions comprise small interfering nucleic acid molecule that suppresses expression of target gene involved in energy metabolism pathway within tumor cell, in biosynthesis of nucleotides, in glycogen metabolism, in transport of sugars, amino acids
06/19/2008DE102006061517A1 Angioinhibin Angioinhibin
06/19/2008DE102006058450A1 Zubereitungen zur Hemmung der Prostaglandin E2 Synthese Preparations for the inhibition of prostaglandin E2 synthesis
06/19/2008DE102004052877B4 Stabile wässrige Formulierungen eines Platin-Derivats A stable aqueous formulations of a platinum derivative
06/19/2008CA2673097A1 Fused heterocyclic compound
06/19/2008CA2672585A1 Composition containing agaricus blazei murill
06/19/2008CA2672581A1 Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same
06/19/2008CA2672565A1 Imidazothiazole derivatives
06/19/2008CA2672468A1 Human antibodies that bind cd70 and uses thereof
06/19/2008CA2672367A1 3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
06/19/2008CA2672226A1 Anti-inflammatory compounds containing compositions for treatment of cancer
06/19/2008CA2672101A1 Compounds and compositions as kinase inhibitors
06/19/2008CA2671845A1 Phosphoinositide 3-kinase inhibitor compounds and methods of use
06/19/2008CA2671336A1 Epothilone analogues modified at positions c12-c13 as anticancer drugs
06/19/2008CA2670728A1 Pyridine derivatives used as xiap inhibitors
06/19/2008CA2670707A1 Compositions and methods for treating a neoplasm
06/18/2008EP1932915A2 Materials and methods relating to improved vaccination strategies
06/18/2008EP1932857A1 Preventive/remedy for cancer
06/18/2008EP1932856A2 IL-8 inhibitors
06/18/2008EP1932845A1 3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
06/18/2008EP1932839A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
06/18/2008EP1932834A1 Aromatic 1,4-DI-Carboxylamides and their use
06/18/2008EP1932830A1 Sulfonamides and their use as a medicament
06/18/2008EP1932541A1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent
06/18/2008EP1932537A1 Expression of transgenic T cell receptors in LAK-T cells
06/18/2008EP1932534A1 Method of inhibiting angiogenesis by using ephrin b2
06/18/2008EP1932527A1 The use of phthalide derivatives
06/18/2008EP1932518A1 Statin containing compositions for treatment of cancer
06/18/2008EP1932516A1 Anti-inflammatory compounds containing compositions for treatment of cancer
06/18/2008EP1931735A1 High-purity texaphyrin metal complexes
06/18/2008EP1931710A2 Engineered anti-il-23 antibodies
06/18/2008EP1931694A1 Aptamers comprising arabinose modified nucleotides
06/18/2008EP1931677A2 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
06/18/2008EP1931676A1 Pyrazolopyrimidines as protein kinase inhibitors
06/18/2008EP1931675A2 Pyrazolo(1, 5a) pyrimidines as protein kinase inhibitors
06/18/2008EP1931674A2 Deazapurines useful as inhibitors of janus kinases
06/18/2008EP1931671A1 Alkyl 4- [4- (5-oxo-2, 3, 5, 11a-tetrahyd0-5h-pyrr0l0 [2, 1-c][1, 4]benzodiazepine-8-yloxy) -butyrylamino]-1h-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease
06/18/2008EP1931670A1 Pyridopyrimidinone inhibitors of pi3k
06/18/2008EP1931669A1 Kinase inhibitors
06/18/2008EP1931662A1 Pyrimidine derivatives for the inhibition of igf-ir tyrosine kinase activity
06/18/2008EP1931645A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
06/18/2008EP1931641A2 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI
06/18/2008EP1931636A1 Isoquinolines as igf-1r inhibitors
06/18/2008EP1931385A2 (s)-6-methyloxaalkyl exemestane compounds and related methods of use
06/18/2008EP1931377A1 Cd4+ t survivin epitopes and uses thereof
06/18/2008EP1931343A2 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
06/18/2008EP1931339A1 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
06/18/2008EP1931334A2 Functionalized drugs and polymers derived therefrom
06/18/2008EP1931331A1 Combinations comprising dmxaa for the treatment of cancer
06/18/2008EP1931205A2 Transglutaminase inhibitors and methods of use thereof
06/18/2008EP1853588B1 Chemical compounds
06/18/2008EP1802625B1 Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
06/18/2008EP1684763B1 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agent
06/18/2008EP1487402B1 Composition including a pigment assembly comprising a mica core
06/18/2008EP1485378B1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/18/2008EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
06/18/2008EP1257648B1 Antagonistic selective binding agents of osteoprotegerin binding protein
06/18/2008EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
06/18/2008EP1198479B1 Neovascular-targeted immunoconjugates
06/18/2008EP1115879B1 Retroviral particles protected against complement mediated destruction
06/18/2008EP1115746B1 Antibodies to mammalian langerhans cell antigen and their uses
06/18/2008EP1064027B1 Apo-2 ligand-anti-her-2 antibody synergism
06/18/2008CN101203607A Anti-CD-20 monoclonal antibody
06/18/2008CN101203549A Process for production of polymerized coordination compound of platinum complex
06/18/2008CN101203519A 2-amido-6-amino-8-oxopurine derivatives as ToII-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
06/18/2008CN101203514A Substituted pyrido (2 , 3-d) pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders
06/18/2008CN101203494A Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
06/18/2008CN101203493A Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
06/18/2008CN101203489A Oxindole derivatives
06/18/2008CN101203486A Dicarbonic acid derivatives, metastasis inhibitors and agents increasing chemotherapeutic activity of anti-tumor preparations, method for enhancing the efficiency of cytostatics and metastasis process
06/18/2008CN101203247A Targeted chimeric molecules for cancer therapy
06/18/2008CN101203230A Modulating angiogenesis with NOD factors such as glucosamine oligosaccharides
06/18/2008CN101203224A Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of Tie-2 kinase activity
06/18/2008CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone
06/18/2008CN101200752A Method for separation and preparation of eburicoic acid compound by using hirschioporus versatilis fermentation liquor
06/18/2008CN101200719A Liver cancer related gene DLK1 and uses thereof
06/18/2008CN101200488A Novel biogastrone acid derivatives, preparation method and medical uses thereof
06/18/2008CN101200482A shRNA accelerating carcinoma cell apoptosis and uses thereof
06/18/2008CN101200469A Separation of regioisomers of metal phthalocyanines
06/18/2008CN101200467A New compound generated by streptomycete and preparation method thereof
06/18/2008CN101200465A Decahydronaphthalene compounds and medical uses thereof
06/18/2008CN101200460A Dihydrobenzopyrans ketone compound and uses thereof
06/18/2008CN101200457A Dihydro pteridinone, method for making the same and uses as pharmaceutical preparation thereof
06/18/2008CN101200448A Beta-elemene derivatives as well as Re complex and 188Re marker thereof
06/18/2008CN101200446A 3-pyrrole ring caproic subunit-2-dihydroindolone derivatives and uses thereof
06/18/2008CN101200426A Hydroxyl benzoic anhydride dimer compound, preparation method and uses thereof
06/18/2008CN101199862A B7-1, CD40L mass particle mixture
06/18/2008CN101199861A DNA vaccine for anti-liver cancer
06/18/2008CN101199860A Cancer suppressing agent
06/18/2008CN101199859A Inhibition lung cancer transfer and lung transfer tumor gene medicament
06/18/2008CN101199857A Combination of mPEG-PLA-tree alkali medicament
06/18/2008CN101199844A Liquid agent of stable anti-EGFR chimeric antibody
1 ... 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 ... 2211